Monday, March 14, 1994
Digesting acquisitions can be a slow process - 18-24 months seems about average - and
International Murex Technologies Corp. appears to have just about completed the task of
digesting its February 1992 acquisition of Wellcome Diagnostics.
Year-end results for the Norcross, Ga.-based diagnostics company put it in the black
for the first time since the acquisition, with net income of $2.7 million (16 cents per
share) versus a loss of $17.6 million ($1.17) in 1992, despite adverse movements in
Much of the credit for the turnaround goes to President and COO David Tholen, who
joined MXX in June 1993 after 21 years at Abbott Laboratories.
Attention to detail
Tholen's common-sense measures